Who
Michal Nath Puri
Chief Human Resources Officer
Company insider
Files Form 4 as: Chief Human Resources Officer, NovoCure.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $137K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Oct 2023
- Last trade
- 30 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 1 Jul 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $21K1,905 at $11.15 | filing |
| 30 Jun 2026filed 1 Jul 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $21K1,905 at $11.15 | filing |
| 4 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $15K1,100 at $13.31 | filing |
| 4 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $15K1,100 at $13.31 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —40,100 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —58,672 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —58,672 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —40,100 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $20K1,441 at $13.66 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $20K1,441 at $13.66 | filing |
| 31 Dec 2025filed 8 Jan 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $111 at $10.99 | filing |
| 31 Oct 2025filed 4 Nov 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code F | $9,641752 at $12.82 | filing |
| 30 Jun 2025filed 1 Jul 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $13K833 at $15.13 | filing |
| 4 Mar 2025filed 6 Mar 2025 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | $1.5M81,499 at $18.19 | filing |
| 4 Mar 2025filed 6 Mar 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $1000K54,975 at $18.19 | filing |
| 27 Feb 2025filed 3 Mar 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $23K1,162 at $19.92 | filing |
| 27 Feb 2025filed 3 Mar 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $4,624225 at $20.55 | filing |
| 27 Feb 2025filed 3 Mar 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $23K1,162 at $19.92 | filing |
| 27 Feb 2025filed 3 Mar 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $4,624225 at $20.55 | filing |
| 31 Oct 2024filed 4 Nov 2024 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $13K810 at $15.79 | filing |
News
Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Michal Nath Puri; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.